Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed director
Quarterly results
Director departure
CC transcript
ALBIREO PHARMA, INC. (ALBO) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/14/2023 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
03/09/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/09/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/09/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/09/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/09/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/08/2023 SC 13G/A BlackRock Inc. reports a 2.4% stake in ALBIREO PHARMA, INC.
03/03/2023 4 Chiswell David (Director) has filed a Form 4 on ALBIREO PHARMA, INC.
Txns: Unknown transaction of 56,278 shares @ $0
Disposed/sold 8,000 options to buy @ $19.47, valued at $155.8k
Disposed/sold 8,000 options to buy @ $36.87, valued at $295k
Disposed/sold 8,000 options to buy @ $27.89, valued at $223.1k
Disposed/sold 5,500 options to buy @ $31.22, valued at $171.7k
Disposed/sold 5,500 options to buy @ $32.53, valued at $178.9k
Disposed/sold 3,000 options to buy @ $17.05, valued at $51.2k
Disposed/sold 4,500 options to buy @ $18.54, valued at $83.4k
03/02/2023 4 Alesina Susan (Director) has filed a Form 4 on ALBIREO PHARMA, INC.
Txns: Disposed/sold 16,000 options to buy @ $25.86, valued at $413.8k
03/02/2023 4 Okey Stephanie (Director) has filed a Form 4 on ALBIREO PHARMA, INC.
Txns: Disposed/sold 8,000 options to buy @ $19.47, valued at $155.8k
Disposed/sold 8,000 options to buy @ $36.87, valued at $295k
Disposed/sold 8,000 options to buy @ $27.89, valued at $223.1k
Disposed/sold 5,500 options to buy @ $31.22, valued at $171.7k
Disposed/sold 5,500 options to buy @ $32.53, valued at $178.9k
Disposed/sold 11,000 options to buy @ $30.68, valued at $337.5k
03/02/2023 4 Harford Simon N.R. (CFO and Treasurer) has filed a Form 4 on ALBIREO PHARMA, INC.
Txns: Unknown transaction of 13,739 shares @ $0
Disposed/sold 23,700 options to buy @ $34.88, valued at $826.7k
Disposed/sold 31,500 options to buy @ $24.67, valued at $777.1k
Disposed/sold 31,500 options to buy @ $24.04, valued at $757.3k
Disposed/sold 37,500 options to buy @ $27.98, valued at $1M
Disposed/sold 73,950 restricted stock units @ $0
03/02/2023 4 Cooper Ronald Harold Wilfred (President and CEO) has filed a Form 4 on ALBIREO PHARMA, INC.
Txns: Unknown transaction of 33,094 shares @ $0
Disposed/sold 132,150 options to buy @ $26.75, valued at $3.5M
Disposed/sold 43,027 options to buy @ $19.19, valued at $825.7k
Disposed/sold 93,000 options to buy @ $34.88, valued at $3.2M
Disposed/sold 124,000 options to buy @ $24.67, valued at $3.1M
Disposed/sold 124,000 options to buy @ $24.04, valued at $3M
Disposed/sold 123,750 options to buy @ $30.68, valued at $3.8M
Disposed/sold 60,000 options to buy @ $24.48, valued at $1.5M
Disposed/sold 19,422 options to buy @ $1, valued at $19.4k
Disposed/sold 155,381 options to buy @ $1, valued at $155.4k
Disposed/sold 219,350 restricted stock units @ $0
03/02/2023 4 STRECK PAUL (Chief Medical Officer) has filed a Form 4 on ALBIREO PHARMA, INC.
Txns: Disposed/sold 118,966 restricted stock units @ $0
03/02/2023 4 Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.
Txns: Unknown transaction of 22,242 shares @ $0
Disposed/sold 23,700 options to buy @ $34.88, valued at $826.7k
Disposed/sold 31,500 options to buy @ $24.67, valued at $777.1k
Disposed/sold 37,500 options to buy @ $28.76, valued at $1.1M
Disposed/sold 75,513 restricted stock units @ $0
03/02/2023 4 Graham Michelle (Chief Human Resources Officer) has filed a Form 4 on ALBIREO PHARMA, INC.
Txns: Unknown transaction of 5,543 shares @ $0
Disposed/sold 23,700 options to buy @ $34.88, valued at $826.7k
Disposed/sold 31,500 options to buy @ $24.67, valued at $777.1k
Disposed/sold 37,500 options to buy @ $19.32, valued at $724.5k
Disposed/sold 50,950 restricted stock units @ $0
03/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/02/2023 4 Gutch Michael (Director) has filed a Form 4 on ALBIREO PHARMA, INC.
Txns: Disposed/sold 8,000 options to buy @ $19.47, valued at $155.8k
Disposed/sold 8,000 options to buy @ $36.87, valued at $295k
Disposed/sold 8,000 options to buy @ $27.89, valued at $223.1k
Disposed/sold 5,500 options to buy @ $31.22, valued at $171.7k
Disposed/sold 5,500 options to buy @ $32.53, valued at $178.9k
Disposed/sold 3,000 options to buy @ $17.05, valued at $51.2k
Disposed/sold 4,500 options to buy @ $23.82, valued at $107.2k
03/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/02/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/02/2023 4 Carter Martha J. (Chief Regulatory Officer) has filed a Form 4 on ALBIREO PHARMA, INC.
Txns: Unknown transaction of 3,656 shares @ $0
Disposed/sold 15,900 options to buy @ $26.75, valued at $425.3k
Disposed/sold 23,700 options to buy @ $34.88, valued at $826.7k
Disposed/sold 3,250 options to buy @ $24.48, valued at $79.6k
Disposed/sold 62,009 options to buy @ $29.76, valued at $1.8M
Disposed/sold 2,500 options to buy @ $19.19, valued at $48k
Disposed/sold 19,688 options to buy @ $24.04, valued at $473.3k
Disposed/sold 31,500 options to buy @ $24.67, valued at $777.1k
Disposed/sold 30,000 options to buy @ $30.68, valued at $920.4k
Disposed/sold 65,850 restricted stock units @ $0
03/02/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/02/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/02/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/02/2023 4 Duncan Jason (Chief Legal Officer and GC) has filed a Form 4 on ALBIREO PHARMA, INC.
Txns: Unknown transaction of 3,296 shares @ $0
Disposed/sold 15,900 options to buy @ $26.75, valued at $425.3k
Disposed/sold 10,063 options to buy @ $24.04, valued at $241.9k
Disposed/sold 24,337 options to buy @ $24.67, valued at $600.4k
Disposed/sold 23,700 options to buy @ $34.88, valued at $826.7k
Disposed/sold 37,500 options to buy @ $30.68, valued at $1.2M
Disposed/sold 65,850 restricted stock units @ $0
03/02/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/02/2023 4 Mattsson Jan (Chief Scientific Officer) has filed a Form 4 on ALBIREO PHARMA, INC.
Txns: Unknown transaction of 35,524 shares @ $0
Disposed/sold 23,700 options to buy @ $34.88, valued at $826.7k
Disposed/sold 31,500 options to buy @ $24.67, valued at $777.1k
Disposed/sold 31,500 options to buy @ $24.04, valued at $757.3k
Disposed/sold 40,000 options to buy @ $30.68, valued at $1.2M
Disposed/sold 13,000 options to buy @ $24.48, valued at $318.2k
Disposed/sold 20,000 options to buy @ $19.19, valued at $383.8k
Disposed/sold 73,950 restricted stock units @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy